HFA Premium Access

Initial clinical experience with subcutaneous furosemide in patients with fluid overload.

Congress Presentation

About the speaker

Doctor Stuart Russell

Duke University Health System, Durham (United States of America)
1 presentation
0 follower

3 more presentations in this session

Furosemide 2.0: a novel formulation of furosemide for subcutaneous administration.

Speaker: Professor B. Pitt (Ann Arbor, US)

Thumbnail

Pharmacokinetics of furosemide following subcutaneous administration of a novel injectable formulation.

Speaker: Professor R. De Boer (Rotterdam, NL)

Thumbnail

Rationale for and design of the SUBQ-HF clinical study.

Speaker: Professor G. Felker (Durham, US)

Thumbnail

Access the full session

Furosemide 2.0: furosemide for subcutaneous administration: a novel tool in the management of the pre and post acute heart failure patient

Speakers: Doctor S. Russell, Professor B. Pitt, Professor R. De Boer, Professor G. Felker
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk